Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Aspira Women's Health Inc. (AWHL)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.2M | $9.2M | $9.2M | $8.2M | $6.8M | $4.7M | $4.5M | $3.1M | $3.1M | $2.6M | $2.2M | $2.5M | $2.6M | $2.1M | $1.9M | $1.2M |
| Gross profit | $5.9M | $5.5M | $5.3M | $4.3M | $3.1M | $1.2M | $1.2M | −$89,000 | $207,000 | −$56,000 | −$132,000 | $1.3M | $2.4M | $2.0M | $1.8M | $1.1M |
| Research & development | $2.9M | $3.3M | $4.0M | $5.9M | $5.3M | $2.1M | $1.0M | $550,000 | $837,000 | $2.2M | $3.8M | $4.7M | $2.6M | $2.2M | $5.4M | $3.8M |
| Operating expenses | $13.8M | $21.8M | $24.1M | $35.5M | $35.7M | $19.2M | $16.5M | $11.2M | $10.6M | $14.9M | $19.1M | $20.5M | $11.3M | $11.4M | $19.4M | $15.7M |
| Operating income | −$7.9M | −$16.3M | −$18.9M | −$31.1M | −$32.6M | −$18.0M | −$15.3M | −$11.3M | −$10.4M | −$15.0M | −$19.2M | −$19.2M | −$8.9M | −$9.4M | −$17.6M | −$14.6M |
| EBITDAderived | −$7.8M | −$16.2M | −$18.7M | −$30.9M | −$32.3M | −$17.7M | −$14.9M | −$10.7M | −$9.7M | −$14.2M | −$19.0M | −$19.1M | −$8.8M | −$9.3M | −$17.6M | −$14.5M |
| Net income | −$12.8M | −$13.1M | −$16.7M | −$29.9M | −$31.7M | −$17.9M | −$15.2M | −$11.4M | −$10.5M | −$15.0M | −$19.1M | −$19.2M | −$8.8M | −$7.1M | −$17.8M | −$19.0M |
| Basic EPSper diluted share | -$0.37 | -$0.93 | -$1.81 | -$3.85 | -$4.27 | -$0.18 | -$0.18 | -$0.16 | -$0.20 | -$0.29 | -$0.41 | -$0.53 | -$0.42 | -$0.48 | -$1.25 | -$1.83 |
| Diluted EPSper diluted share | -$0.37 | -$0.93 | -$1.81 | -$3.85 | -$4.27 | -$0.18 | -$0.18 | -$0.16 | -$0.20 | -$0.29 | -$0.41 | -$0.53 | -$0.42 | -$0.48 | -$1.25 | -$1.83 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026Form 4 | SCHULER JACK WTenPercentOwner | BuyCommon Stock · indirect | 222.2K | $0.45 | $100.0K | 4.05M |
| Jun 5, 2026Form 4 | SCHULER JACK WTenPercentOwner | BuyWarrant (Right to Buy) · derivative · indirect | 300.0K | $0.00 | $0.00 | 300.0K |
| Sep 17, 2025Form 4/A | Fraser John DDirector | BuyCommon Stock | 16.4K | $0.45 | $7.4K | 566.4K |
| Sep 17, 2025Form 4/A | Fraser John DDirector | BuyWarrant (Right to Buy) · derivative | 12.3K | $0.00 | $0.00 | 12.3K |
| Sep 17, 2025Form 4/A | cohen Jeffrey kDirector | BuyCommon Stock | 55.6K | $0.45 | $25.0K | 374.9K |